tbuckley/cabot-search huggingface dataset:
DANGER OF BOVINE TUBERCULOSIS.
Journal: JAMA (1901)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Lipoprotein(a) in coronary heart disease. Is it a risk factor after all?
Authors: V. Gurewich
Journal: JAMA (1994)

The role of lipoprotein(a) [Lp(a)] in coronary heart disease (CHD), once considered to be well established, has recently been put into question. For example, in a prospective, nested case-control study of the Helsinki Heart Study participants, Jauhiainen et al<sup>1</sup>found no significant increase in risk of CHD associated with higher levels of Lp(a) among 138 hyperlipidemic men who developed coronary events compared with 130 controls. A similar lack of association between Lp(a) and clinical CHD was reported by Simons et al<sup>2</sup>from a cross-sectional analysis of 1202 men and 1512 women older than 60 years. The skewed and broad distribution of Lp(a) levels, ranging from 1.0 mg/dL (0.03 mmol/L) to 210.0 mg/dL (5.25 mmol/L), was strikingly similar in the two groups. Finally, in a report published recently inThe JOURNALinvolving the prospective Physicians' Health Study, Ridker et al<sup>3</sup>found a "virtually identical" Lp(a) distribution among 296
Effluvial Aphrodite
Journal: JAMA (1971)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
In this issue
Authors: Ezzie Hutchinson, Kristine Novak, Nicola Mccarthy, Jenny Bangham, Oliver Childs, Claudia Bentley, Emma Green, Art Controller, Nicola Hawes, Susanne Harris, Judith Shadwell, Deputy Production, Simon Fenwick, Luisa Estanislao, Sam Arr-Jones, Sheryl Ocampo, Amanda Ward, Catherine Alexander, Puja Kamdar, Christina Large, Alexander Thurrell, Annette Thomas, Peter Collins, Hugh Blackbourn, Jenny Henderson, Tony Rudland, Philip Campbell, Fabien Savenay, Anna Duguid, Kelly Lane, James Mcquat, Yvonne Strong, Natalie Smith
Journal: Nature reviews. Cancer (2005)
The JAMA Journal Club
Authors: M. I. Gannon
Journal: JAMA (1989)

The American Medical Association (AMA) provides continuing medical education to physicians worldwide through<i>JAMA</i>, the 11 international editions of<i>JAMA</i>, and the 9 AMA specialty journals. The regular English-language<i>JAMA</i>is received by nearly 400 000 recipients in 132 countries. The international editions are received by approximately another 300 000, and the specialty journals have an aggregate distribution of about 360 000. Authors of articles accepted for publication, therefore, reach and communicate with hundreds of thousands of physicians and, through the media, the public at large. This week the AMA launches a new continuing medical education program that will extend and amplify the educational value of these journals many times over—the<i>JAMA</i>Journal Club. The concept is deceptively simple. The reading of journal articles, which physicians have always indicated as a primary source of their continuing medical education,<sup>1</sup>is combined with small-group discussion, which educators have always recognized as
Phase I Clinical Trial Evaluating Abatacept in Patient with Steroid-Refractory Chronic Graft Versus Host Disease
Authors: Myrna R. Nahas, Robert J. Soiffer, Edwin P. Alyea, Jon Arnason, Robin Joyce, Joseph H. Antin, Vincent T. Ho, Dina Stroopinsky, James D. Levine, Malgorzata McMasters, Salvia Jain, Ayad Hamdan, Mary Paty Bryant, Emma Logan, Josie Bazemore, Jeremy Stewart, Amy Joyce, Susan Stephenson, Abigail J. Washington, Leandra Cole, Athalia Rachel Pyzer, Rebecca Karp Leaf, David E. Avigan, Jacalyn Rosenblatt
Journal: Blood (2016)
The cost-effectiveness of cervical cancer screening for low-income elderly women
Authors: J. S. Mandelblatt
Journal: JAMA (1988)

Controversy surrounds prevention policy for the elderly. While some cost-effectiveness analyses have been done for the general elderly population, to our knowledge no study has examined the provision of preventive services to a low-income elderly population. We conducted a study of the cost-effectiveness of a cervical cancer screening program for infrequently screened elderly women attending an urban municipal hospital clinic. The results of Papanicolaou testing were abnormal (malignant or premalignant) in 11 of 816 women screened. This early detection of cervical neoplasia saved $5907 and 3.7 years of life per 100 Papanicolaou tests. When average medical costs per year of life extended by screening were included, the program cost $2874 per year of life saved. Comprehensive sensitivity analyses performed on competing medical and economic points of view did not change the conclusion of a favorable cost-effectiveness ratio for screening. Our findings indicate that the benefits from some prevention programs for the elderly can offset the costs of these programs. More research is needed to guide public policy on prevention for selected population groups. (<i>JAMA</i>1988;259:2409-2413)
Reply: Partial Gastrectomy: A Risk Factor for Pancreatic Cancer?
Authors: Thomas M. Mack, M.D., M.P.H.
Journal: JNCI Journal of the National Cancer Institute (1986)

Journal Article Reply: Partial Gastrectomy: A Risk Factor for Pancreatic Cancer? Get access Thomas M. Mack, M.D., M.P.H. Thomas M. Mack, M.D., M.P.H. Department of Preventive Medicine, School of Medicine, University of Southern California, 2025 Zonal Avenue, Los Angeles, California 90033 Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 77, Issue 2, August 1986, Page 592, https://doi.org/10.1093/jnci/77.2.592 Published: 01 August 1986
Technique and Results of Grafting Skin.
Journal: JAMA (1931)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
REVOCATION OF LIQUOR PRESCRIPTION PERMITS
Journal: JAMA (1926)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Anatomy of Animal Types for Students of Zoology
Journal: JAMA (1934)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The Outlook in Cancer Patients Who Previously Had Skin Cancer
Journal: Annals of Internal Medicine (1999)

Summaries for Patients2 November 1999The Outlook in Cancer Patients Who Previously Had Skin CancerSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-131-9-199911020-00035 SectionsAboutFull Text ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail What is the problem and what is known about it so far?It is known that people who have previously had a common type of skin cancer (squamous-cell cancer) are at increased risk for other types of nonskin cancers. What is not known, however, is whether people who had squamous-cell skin cancer in the past do any worse when they develop other (second) cancers than people who develop these same other cancers but never had skin cancer.Why did the researchers do this particular study?The researchers wanted to find out whether the outlook for cancer patients who have had ... Author, Article, and Disclosure InformationAffiliations: The summary below is from the full report titled “Is History of Squamous-Cell Skin Cancer a Marker of Poor Prognosis in Patients with Cancer?.” It is in the 2 November 1999 issue of Annals of Internal Medicine (volume 131, pages 655-649). The authors are J. Askling, P. Sørensen, A. Ekbom, M. Frisch, M. Melbye, B. Glimelius, and H. Hjalgri.Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoIs History of Squamous-Cell Skin Cancer a Marker of Poor Prognosis in Patients with Cancer? Johan Askling , Per Sørensen , Anders Ekbom , Morten Frisch , Mads Melbye , Bengt Glimelius , and Henrik Hjalgrim Metrics 2 November 1999Volume 131, Issue 9Page: 655KeywordsBreast cancerChronic lymphocytic leukemiaColonColorectal cancerDeath ratesLung and intrathoracic tumorsLymphoma ePublished: 15 August 2000 Issue Published: 2 November 1999 Copyright & PermissionsCopyright © 1999 by American College of Physicians. All Rights Reserved.Loading ...
The Case of the Missing Fecalith
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Five-Year Clinical and Functional Outcome Comparing Bypass Surgery and Angioplasty in Patients With Multivessel Coronary Disease&lt;subtitle&gt;A Multicenter Randomized Trial&lt;/subtitle&gt;
Journal: JAMA (1997)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Neuroleptic malignant syndrome. Successful treatment with bromocriptine
Authors: P. S. Mueller
Journal: JAMA (1983)

THE NEUROLEPTIC malignant syndrome (NMS) is characterized by severe extrapyramidal dysfunction, hyperthermia, and autonomic disturbances following neuroleptic usage.<sup>1,2</sup>This relatively uncommon, potentially lethal syndrome carries a mortality of 20%, yet it is largely unrecognized by physicians and most workers engaged in the neurosciences. Anticholinergic or benzodiazepine treatment, commonly used for neuroleptic neurological side effects, is usually of limited success in the treatment of NMS; a long hospital course with considerable physical disability often is a result in those patients who survive.<sup>3</sup>We present two patients with NMS: the first treated in the usual fashion in our medical intensive care unit (ICU), the second on our psychiatric ward, with the rapidly successful and first reported usage of bromocriptine mesylate. <h3>Report of Cases</h3><h3>Case 1.—</h3> A 28-year-old married woman had been well until Feb 2, 1977, when an acute schizophrenic psychosis with paranoia and catatonia rapidly developed. During her first
In This Issue
Journal: Journal of Clinical Investigation (2011)

B cells bad for lymphoma therapyThere are many types of non-Hodgkin lymphomas (NHLs); together, they account for approximately 4% of all cancer diagnoses.The majority of NHLs arise from B cells and express the B cell marker CD20.Treatment therefore often includes the chimeric CD20 mAb rituximab.Although effective in many patients, for a substantial number, it does not result in a durable response.Horikawa, Minard-Colin, and colleagues set out to investigate whether this is because treatment with CD20 mAbs fails to deplete all endogenous nonmalignant B cells in some patients, in particular those cells in the tissues (4268)(4269)(4270)(4271)(4272)(4273)(4274)(4275)(4276)(4277)(4278)(4279)(4280).In a mouse model of NHL, the authors found that if endogenous tissue B cells were not eliminated by treatment with a CD20 mAb, the antilymphoma efficacy of treatment with CD20 mAbs was substantially reduced.Further analysis identified a rare population of IL-10-producing regulatory B cells (B10 cells) as the inhibitors of lymphoma clearance in these mice.Importantly, coadministration of a TLR3 agonist abrogated the inhibitory effects of endogenous B10 cells during CD20 mAb treatment.Horikawa, Minard-Colin, and colleagues therefore suggest that either eliminating B10 cells or coadministrating TLR3 agonists could provide a way to improve the efficacy of CD20 mAb therapies in individuals with NHL.
Editorial Ethics
Authors: Lois DeBakey
Journal: JAMA (1974)

<h3>To the Editor.—</h3> It is difficult to see how Dr. Vaisrub, in his editorial on "Ethical Priorities" (227:434, 1974), arrived at his opening Voltairian condensation of the statement on "Ethical Experimentation and the Editor" by the Committee on Editorial Policy of the Council of Biology Editors. Nowhere in our Committee's statement can I find a basis for such paraphrasing. The instances in which "valuable information" derived from unethical experimentation "may never get into print" are probably more hypothetical than real, and only rarely, if ever, would society be seriously deprived if the dissemination of such information awaited its derivation by ethical means. The availability of human subjects and of funds for future medical research, on the other hand, would be sharply reduced by the public outrage ensuing from publication of unethically obtained data. "Discourteous, underhanded, even unethical" are undoubtedly the adjectives that authors<i>would</i>apply to the editorial practice of
THE EVILS OF TEA-DRINKING.
Journal: JAMA (1897)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Infectious mononucleosis in the elderly
Authors: W. P. Corr
Journal: JAMA (1966)

<h3>To the Editor:—</h3> When an elderly patient, especially one with known degenerative vascular disease, suddenly seems to deteriorate mentally, it is tempting to make a diagnosis of "minor stroke." But many other illnesses can cloud an aging person's mind, with only a benign cause for the ominous symptoms. Such was the happy outcome in this case of infectious mononucleosis in a 70-year-old man. The patient, a retired teacher, normally quite alert, had had a myocardial infarction in February 1964 and another in March 1965. At the time of his first episode a diminished right carotid pulse had been noted. One week before admission to the hospital on May 18, 1965, he noted that he was no longer able to think clearly or rapidly. This feeling had persisted and this dull state contributed to two automobile accidents. In one he had veered off his driveway into some bushes and in the